Summary for ARTG Entry:
MONTELUKAST TN 5 montelukast (as sodium) 5 mg chewable tablet blister pack
ARTG entry for
Torrent Australasia Pty Ltd
Coleman & Greig L9/10 George St,PARRAMATTA, NSW, 2150
ARTG Start Date
Drug Safety Evaluation Branch
Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods
Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered
or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
1. MONTELUKAST TN 5 montelukast (as sodium) 5 mg chewable tablet blister pack
Single Medicine Product
See Product Information and Consumer Medicine Information for this product
Prophylaxis and treatment of chronic asthma in adults and children 2 years of age and older. Symptomatic treatment of seasonal allergic rhinitis.
Additional Product information
Store below 30
Protect from Moisture
Protect from Light
Pack Size/Poison information
(S4) Prescription Only Medicine
1. MONTELUKAST TN 5 montelukast sodium 5 mg tablet blister pack
Route of Administration
pink coloured, round shaped, uncoated tablets with score line on both sides
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 29.11.2017 at 12:41:33 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information